Overview
Melanotan II is a synthetic cyclic heptapeptide analog of α-MSH, the endogenous regulator of pigmentation. Developed originally as a pharmacological tool for melanocortin receptor biology, its lactam-bridged cyclic structure gives it conformational rigidity and improved metabolic stability relative to the linear parent peptide — and it binds measurably across MC1R, MC3R, and MC4R rather than acting selectively at a single subtype.
Mechanism of Action
MT-II behaves as a non-selective melanocortin receptor agonist: radioligand assays characterize high-affinity binding at MC1R, MC3R, and MC4R with much lower affinity at MC2R and MC5R, and functional assays show full agonism at MC1R and MC4R with partial agonism at MC3R. At MC1R, receptor activation raises intracellular cAMP and drives PKA-dependent CREB phosphorylation, upregulating MITF and the rate-limiting melanogenic enzyme tyrosinase — a cascade characterized in melanocyte and melanoma cell preparations where MT-II shows potency well beyond α-MSH.
Specifications
- Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
- Form: Lyophilized powder
- CAS Number: 121062-08-6
- Molecular Weight: 1024.18 Da
- Chemical Formula: C₅₀H₆₉N₁₅O₉
- Synonyms: MT-II, MT-2, Melanotan 2
Research Applications
- Melanocortin receptor profiling and subtype selectivity
- cAMP/PKA-CREB signaling research
- Melanogenesis and tyrosinase regulation models
- Peptide conformational stability studies
- Endocrine signaling models

